Objective:Fibrosis-related biomarkers, such as Fibroblast growth factor 23 (FGF-23) and Galectin-3, have been shown to promote myocardial fibrosis and arterial stiffness. However, it remains unknown whether these biomarkers contribute to… Click to show full abstract
Objective:Fibrosis-related biomarkers, such as Fibroblast growth factor 23 (FGF-23) and Galectin-3, have been shown to promote myocardial fibrosis and arterial stiffness. However, it remains unknown whether these biomarkers contribute to the development of cognitive dysfunction.Design and method:A t
               
Click one of the above tabs to view related content.